Back to search

Article

Cost-Effectiveness Analysis of Pneumococcal Vaccine in the Pediatric Population: A Systematic Review

2024-08-12

Abstract excerpt

Pneumococcal disease, caused by Streptococcus pneumoniae is the leading cause of high mortality in children worldwide. The tremendous direct cost of hospital admissions and significant indirect costs from productivity loss contributed considerably to the economic burden, with vaccination being the only efficient way against the illness. Our study aims to summarize the cost-effectiveness of the pneumococcal conjuga...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
61b884b0-f754-5ad6-946a-c3fe235c5f6d
DOI
10.20944/preprints202408.0830.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cost-Effectiveness Analysis of Pneumococcal Vaccine in the Pediatric Population: A Systematic ReviewDOI 10.20944/preprints202408.0830.v1
A model-based evaluation of the cost-effectiveness of paediatric and elderly vaccination against pneumococcal infection in EnglandSemantic proximity
Pneumococcal Diseases Caused by Serotype Replacement in Colombia: A Cost-Effectiveness Analysis of Pneumococcal Conjugate Vaccines in Infants and Its Herd Protection in Older AdultsSemantic proximity
Health-economic burden attributable to novel serotypes in candidate 24- and 31-valent pneumococcal conjugate vaccinesSemantic proximity
The impact of vaccine products, schedules and geographic regions on immunogenicity of pneumococcal vaccines in children under 2 years old: a systematic review and meta-analysisSemantic proximity
Pneumococcal Meningitis in Adults in 2014-2018 After Introduction of Pediatric 13-valent Pneumococcal Conjugate Vaccine in JapanSemantic proximity
Pneumococcal meningitis in adults in 2014-2018 after introduction of pediatric 13-valent pneumococcal conjugate vaccine in Japan.Semantic proximity
Recent advances in the epidemiology and prevention of Streptococcus pneumoniae infectionsSemantic proximity
Impact of the National Vaccination Strategy on the Prevalence of <em>Streptococcus pneumoniae </em>and Its Serotypes Among Clinically Healthy Children Under Six Years of Age During and After the COVID-19 PandemicSemantic proximity
Sustained impact of 10-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Kenya, 2011-2022Semantic proximity
Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012–2015)Semantic proximity
Streptococcus pneumoniae carriage, serotypes, genotypes, and antimicrobial resistance trends among children in Portugal, after introduction of PCV13 in National Immunization Program: A cross-sectional study.Semantic proximity
Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalenceSemantic proximity
Select a neighboring publication to make it the new centre.